Featured Research

from universities, journals, and other organizations

Chronic Knee Pain: Is Surgery The Only Solution?

Date:
December 13, 2007
Source:
BioMed Central
Summary:
A new study published in the online open access journal, BMC Medicine, has revealed that arthroscopic surgery combined with exercise is no better than exercise alone in alleviating chronic knee pain.

The results of a study published in the online open access journal, BMC Medicine indicate that sufferers of chronic patellofemoral syndrome (PFPS), a chronic pain in the front part of the knee, gain no extra benefit from surgery. Furthermore, the authors suggest that giving these patients a therapeutic exercise regime rather than putting them through surgery could save money.

Patellofemoral pain syndrome is often treated with arthroscopic surgery, in which equipment inserted through small incisions in the knee is used to both diagnose the cause of the problem and attempt to fix it.

Jyrki Kettunen of The ORTON Research Institute, in Helsinki, Finland, and colleagues point out that whilst chronic knee pain is a common complaint, there is a lack of evidence that arthroscopic surgery has a better outcome than other forms of treatment including therapeutic exercise.

The team conducted a randomized controlled trial to study the efficacy of arthroscopy compared with exercise in 56 patients with chronic PFPS.

The patients were randomly divided into two groups; the first group was treated with knee arthroscopy and an eight-week home exercise program and the second group was treated with the exercise program only. The researchers assessed the patients after 9 months using the Kujala score for knee pain and mobility. They also estimated the direct healthcare costs per patient.

The researchers found that patients in both groups experienced reduced pain and showed marked improvement in knee mobility, with no significant difference in the average Kujala score between the two groups. Other tests also revealed that the improvements for patients treated with surgery and exercise were almost exactly the same as for the exercise-only patients. However, the average cost of treatment was €901 ($1,333.46) higher per patient who underwent both arthroscopy and exercise therapy.

The researchers also carried out a second follow up at two years and still found no differences in outcome between the two patient groups. They concluded that arthroscopy is not a cost effective treatment for chronic PFPS and that surgery should not be routinely used to treat the condition.

Article: Knee arthroscopy and exercise versus exercise only for chronic patellofemoral pain syndrome. A randomized controlled trial. Jyrki A Kettunen, Arsi Harilainen, Jerker Sandelin, Dietrich Schlenzka, Seppo Seitsalo, Kalevi Hietaniemi, Antti Malmivaara and Urho M Kujala. BMC Medicine (in press) (http://www.biomedcentral.com/bmcmed/)


Story Source:

The above story is based on materials provided by BioMed Central. Note: Materials may be edited for content and length.


Cite This Page:

BioMed Central. "Chronic Knee Pain: Is Surgery The Only Solution?." ScienceDaily. ScienceDaily, 13 December 2007. <www.sciencedaily.com/releases/2007/12/071212201511.htm>.
BioMed Central. (2007, December 13). Chronic Knee Pain: Is Surgery The Only Solution?. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2007/12/071212201511.htm
BioMed Central. "Chronic Knee Pain: Is Surgery The Only Solution?." ScienceDaily. www.sciencedaily.com/releases/2007/12/071212201511.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins